Response to: "Absolute cardiovascular risk: the missing denominator in Lp(a)-guided aspirin therapy in primary prevention" [0.03%]
对"Lp(a)指导的一级预防阿司匹林治疗中缺失的分母(绝对心血管风险)"一文的回应
Rodolfo A Lopes,Carlos A Vergara Sanchez,Michael D Shapiro
Rodolfo A Lopes
Loneliness, unhealthy lifestyle, and incident cardiometabolic disease among middle-aged and older adults across 33 countries: a multicohort study [0.03%]
loneliness，不健康生活方式与33个国家中年人群中新发心血管代谢性疾病风险的多队列研究
Dorothy Yingxuan Wang,Luyao Xie,Qingcui Wu et al.
Dorothy Yingxuan Wang et al.
Aim: Loneliness is common in ageing population, we aim to identify the association between loneliness and cardiometabolic disease (CMD) across diverse settings, particularly cardiometabolic multimorbidity, and investigate...
Pedro Marques-Vidal
Pedro Marques-Vidal
Exercise blood pressure relative to fitness in male elite athletes: stage-specific response patterns and athlete-specific reference limits [0.03%]
男子优秀运动员运动血压与体能的关系：不同阶段的反应模式及运动员个体参考值上限
Pascal Bauer,Vincent Größer,Lea Krieglstein et al.
Pascal Bauer et al.
Aims: An exaggerated blood pressure response (eBPR) to exercise is associated with increased cardiovascular risk. The systolic blood pressure-to-achieved metabolic equivalent (SBP/METpeak) ratio was proposed as a fitness-...
Jules Mesnier,Philippe Gabriel Steg
Jules Mesnier
Prognostic Impact of Sarcopenia Following Myocardial Infarction: A Systematic Review and Meta-analysis of Mortality and Recurrent MI [0.03%]
肌梗死后 sarcopenia 的预后影响：系统评价和死亡率及再发的 meta 分析
Xiaoyong Hu,Djandan Tadum Arthur Vithran,Mane Ngom Ulrich Parfait et al.
Xiaoyong Hu et al.
Aim: Sarcopenia, defined as progressive loss of skeletal muscle mass and function, may influence cardiovascular outcomes, yet its prognostic role after myocardial infarction (MI) remains uncertain. This study aimed to ass...
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial [0.03%]
DAN-RSV试验中老年房颤患者RSV疫苗的效果：一项预先指定的分析
Caroline Espersen,Mats C H Lassen,Niklas Dyrby Johansen et al.
Caroline Espersen et al.
Aims: Atrial fibrillation (AF) is a risk factor for respiratory syncytial virus (RSV)-related adverse cardiac events. This prespecified analysis of the DAN-RSV trial investigated RSVpreF vaccine effectiveness (VE) against...
Interaction Between Air Pollution and Genetic Predisposition to Blood Pressure and LDL-C on Cardiovascular Events [0.03%]
空气污染与遗传易感性对血压和LDL-C的交互作用及心血管事件的关系
Jean-Eudes Dazard,Fredrick Schumacher,Zhuo Chen et al.
Jean-Eudes Dazard et al.
Aims: Particulate matter ≤2.5μm (PM2.5) air pollution is a leading global environmental risk factor. We investigated the impact of PM2.5 on cardiovascular risk with lifetime genetic predisposition to low-density lipopro...
Evolving guidelines and shared decision-making in elite/professional athletes with cardiovascular conditions [0.03%]
心血管疾病患者的精英/职业运动员的治疗指南和决策制定正在不断发展
Antonio Pelliccia,Mats Borjesson,Jonathan A Drezner
Antonio Pelliccia
Early versus delayed evolocumab treatment and complex coronary artery revascularization [0.03%]
埃伏库莫单抗早期治疗与延迟治疗以及复杂冠状动脉血运重建的关系
Paul M Haller,Prakriti Gaba,Colleen Thomas et al.
Paul M Haller et al.
Background: In FOURIER, the PCSK9 inhibitor evolocumab (Evo) significantly reduced the rate of major adverse cardiovascular events and coronary revascularization. ...